Cargando…
Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events
BACKGROUND: Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events. Smoking...
Autores principales: | Wingrove, James A., Fitch, Karen, Rhees, Brian, Rosenberg, Steven, Voora, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767057/ https://www.ncbi.nlm.nih.gov/pubmed/29329538 http://dx.doi.org/10.1186/s12920-017-0318-6 |
Ejemplares similares
-
A whole blood gene expression-based signature for smoking status
por: Beineke, Philip, et al.
Publicado: (2012) -
Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer
por: Voora, Deepak, et al.
Publicado: (2016) -
'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
por: Shantsila, Eduard, et al.
Publicado: (2008) -
Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015) -
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)